{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:20:27Z","timestamp":1757704827068},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Cardiovascular Quality and Outcomes"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:sec>\n            <jats:title>Background\u2014<\/jats:title>\n            <jats:p>Atrial fibrillation is an important cause of cardioembolic stroke. Oral anticoagulants (OAC) reduce stroke risk but increase the risk of serious bleeding. Left atrial appendage (LAA) procedures have been developed to isolate the LAA from circulating blood flow, as an alternative to OAC. We conducted a systematic review of the benefits and harms of surgical and percutaneous LAA exclusion procedures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and Results\u2014<\/jats:title>\n            <jats:p>We searched multiple data sources, including Ovid MEDLINE, Cochrane, and Embase, through January 7, 2015. Of 2567 citations, 20 primary studies met prespecified inclusion criteria. We abstracted data on patient characteristics, stroke, mortality, and adverse effects. We assessed study quality and graded the strength of evidence using published criteria. Trials found low-strength evidence that percutaneous LAA exclusion confers similar risks of stroke and mortality as continued OAC, but this evidence was limited to the Watchman device in patients eligible for long-term OAC. Observational studies found moderate-strength evidence of serious harms with a variety of percutaneous LAA procedures. There is low-strength evidence that surgical LAA exclusion does not add significant harm during heart surgery for another indication, but evidence on stroke reduction is insufficient.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions\u2014<\/jats:title>\n            <jats:p>There is limited evidence that the Watchman device may be noninferior to long-term OAC in selected patients. Data on effectiveness of LAA exclusion devices is lacking in patients ineligible for long-term OAC. Percutaneous LAA devices are associated with high rates of procedure-related harms. Although surgical LAA exclusion during heart surgery does not seem to add incremental harm, there is insufficient evidence of benefit.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/circoutcomes.115.002539","type":"journal-article","created":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T02:54:47Z","timestamp":1468378487000},"page":"395-405","update-policy":"http:\/\/dx.doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Effectiveness of Left Atrial Appendage Exclusion Procedures to Reduce the Risk of Stroke: A Systematic Review of the Evidence"],"prefix":"10.1161","volume":"9","author":[{"given":"North","family":"Noelck","sequence":"first","affiliation":[{"name":"From the Department of Medicine, VA Portland Healthcare System, Portland, OR (N.N., J.P., D.K.); Department of Medicine, Oregon Health and Science University, Portland (N.N., J.P., D.K.); and VA Evidence-based Synthesis Program, VA Portland Healthcare System, Portland, OR (M.F., R.P., A.L., M.M., K.K., D.K.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Papak","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, VA Portland Healthcare System, Portland, OR (N.N., J.P., D.K.); Department of Medicine, Oregon Health and Science University, Portland (N.N., J.P., D.K.); and VA Evidence-based Synthesis Program, VA Portland Healthcare System, Portland, OR (M.F., R.P., A.L., M.M., K.K., D.K.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Freeman","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, VA Portland Healthcare System, Portland, OR (N.N., J.P., D.K.); Department of Medicine, Oregon Health and Science University, Portland (N.N., J.P., D.K.); and VA Evidence-based Synthesis Program, VA Portland Healthcare System, Portland, OR (M.F., R.P., A.L., M.M., K.K., D.K.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Paynter","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, VA Portland Healthcare System, Portland, OR (N.N., J.P., D.K.); Department of Medicine, Oregon Health and Science University, Portland (N.N., J.P., D.K.); and VA Evidence-based Synthesis Program, VA Portland Healthcare System, Portland, OR (M.F., R.P., A.L., M.M., K.K., D.K.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Low","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, VA Portland Healthcare System, Portland, OR (N.N., J.P., D.K.); Department of Medicine, Oregon Health and Science University, Portland (N.N., J.P., D.K.); and VA Evidence-based Synthesis Program, VA Portland Healthcare System, Portland, OR (M.F., R.P., A.L., M.M., K.K., D.K.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makalapua","family":"Motu\u2019apuaka","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, VA Portland Healthcare System, Portland, OR (N.N., J.P., D.K.); Department of Medicine, Oregon Health and Science University, Portland (N.N., J.P., D.K.); and VA Evidence-based Synthesis Program, VA Portland Healthcare System, Portland, OR (M.F., R.P., A.L., M.M., K.K., D.K.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karli","family":"Kondo","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, VA Portland Healthcare System, Portland, OR (N.N., J.P., D.K.); Department of Medicine, Oregon Health and Science University, Portland (N.N., J.P., D.K.); and VA Evidence-based Synthesis Program, VA Portland Healthcare System, Portland, OR (M.F., R.P., A.L., M.M., K.K., D.K.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devan","family":"Kansagara","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, VA Portland Healthcare System, Portland, OR (N.N., J.P., D.K.); Department of Medicine, Oregon Health and Science University, Portland (N.N., J.P., D.K.); and VA Evidence-based Synthesis Program, VA Portland Healthcare System, Portland, OR (M.F., R.P., A.L., M.M., K.K., D.K.)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000040"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.2174\/157340310791658730"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(95)00887-X"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199303183281102"},{"key":"e_1_3_4_6_2","unstructured":"Kansagara D Noelck N Papak J Freeman M Low A Motu\u2019apuaka M Kondo K Paynter R. The effectiveness of procedures to remove or occlude the left atrial appendage. Prospero 2015:Crd42015016685. http:\/\/www.Crd.York.Ac.Uk\/prospero\/display_record.Asp?Id=crd42015016685. Accessed May 31 2016."},{"key":"e_1_3_4_7_2","volume-title":"Press: Peer Review of Electronic Search Strategies","author":"Sampson M","year":"2008","unstructured":"Sampson M, McGowan J, Lefebvre C, Moher D, Grimshaw J. Press: Peer Review of Electronic Search Strategies. Ottawa, Canada: Canadian Agency for Drugs and Technologies in Health; 2008"},{"key":"e_1_3_4_8_2","volume-title":"Peer Review of Search Strategies","author":"Relevo R","year":"2012","unstructured":"Relevo R, Paynter R. Peer Review of Search Strategies. Rockville, MD: Agency for Healthcare Research and Quality (publication no. 12-ehc068-ef); 2012"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470712184"},{"key":"e_1_3_4_10_2","unstructured":"Wells GA Shea B O\u2019Connell D Peterson J Welch V Losos M Tugwell P. The newcastle-ottawa scale (nos) for assessing the quality of nonrandomized studies in meta-analyses. Http:\/\/www.Ohri.Ca\/programs\/clinical_epidemiology\/oxford.Asp. Accessed May 31 2016."},{"key":"e_1_3_4_11_2","volume-title":"Grading the Strength of a Body of Evidence When Assessing Health Care Interventions for the Effective Health Care Program of the Agency for Healthcare Research and Quality: An Update. Methods Guide for Comparative Effectiveness Reviews (Prepared by the RTI-UNC Evidence-Based Practice Center Under Contract no. 290-2007-10056-i). Ahrq publication no. 13(14)-ehc130-ef","author":"Berkman ND","year":"2013","unstructured":"Berkman ND, Lohr KN, Ansari M, McDonagh M, Balk E, Whitlock E, Reston J, Bass E, Butler M, Gartlehner G, Hartling L, Kane R, McPheeters M, Morgan L, Morton SC, Viswanathan M, Sista P, Chang S. Grading the Strength of a Body of Evidence When Assessing Health Care Interventions for the Effective Health Care Program of the Agency for Healthcare Research and Quality: An Update. Methods Guide for Comparative Effectiveness Reviews (Prepared by the RTI-UNC Evidence-Based Practice Center Under Contract no. 290-2007-10056-i). Ahrq publication no. 13(14)-ehc130-ef. Rockville, MD: Agency for Healthcare Research and Quality; 2013. http:\/\/www.Effectivehealthcare.Ahrq.Gov\/ehc\/products\/457\/1752\/methods-guidance-grading-evidence-131118.Pdf. Accessed May 31, 2016."},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.04.029"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.01.061"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61343-X"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.114389"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.06.046"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV6I2A35"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2009.05.005"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.976449"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs292"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.25297"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-13-0828"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.24872"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.03.042"},{"key":"e_1_3_4_25_2","first-page":"446","article-title":"Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes.","volume":"21","author":"Park JW","year":"2009","unstructured":"Park JW, Leith\u00e4user B, Gerk U, Vrsansky M, Jung F. Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes. J Invasive Cardiol. 2009;21:446\u2013450.","journal-title":"J Invasive Cardiol"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.03.057"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.03.035"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.22.2864"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.09.054"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2009.03.024"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2013.06.015"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.03.067"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2012.10.016"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2013.07.073"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/0218492312474656"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0901301"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68845-4"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.1513"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.11.010"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-301256"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.130.suppl_2.11584"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.04.025"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta7410"},{"key":"e_1_3_4_44_2","article-title":"Left atrial appendage occlusion study III. Population health research institute\/mcmaster university.","author":"Whitlock R","unstructured":"Whitlock R, Connolly S. Left atrial appendage occlusion study III. Population health research institute\/mcmaster university. Clinicaltrials.Gov identifier: Nct01561651. https:\/\/clinicaltrials.gov\/show\/Nct01561651. Accessed May 31, 2016.","journal-title":"Clinicaltrials.Gov identifier: Nct01561651"},{"key":"e_1_3_4_45_2","unstructured":"Lifetech Scientific (Shenzhen) Co. Ltd. Safety and efficacy study of Lambre LAA closure device for treating af patients who cannot take warfarin. Clinicaltrials.Gov identifier: Nct02029014. https:\/\/clinicaltrials.gov\/show\/Nct02029014. Accessed May 31 2016."},{"key":"e_1_3_4_46_2","unstructured":"Brachmann J Occlutech International AB. Prospective non-randomized safety and efficacy study of a new occluder design for minimally invasive closure of the left atrial appendage (LAA) in patients with atrial fibrillation (OLAAC). Clinicaltrials.Gov identifier: Nct02105584. https:\/\/clinicaltrials.gov\/show\/Nct02105584. Accessed May 31 2016."},{"key":"e_1_3_4_47_2","unstructured":"Osmancik P Charles University Czech Republic Ministry of Health. Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation (PRAGUE-17). ClinicalTrials.gov Identifier: NCT02426944. https:\/\/clinicaltrials.gov\/show\/NCT02426944. Accessed May 31 2016."}],"container-title":["Circulation: Cardiovascular Quality and Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCOUTCOMES.115.002539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T03:31:43Z","timestamp":1715571103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCOUTCOMES.115.002539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1161\/CIRCOUTCOMES.115.002539"],"URL":"https:\/\/doi.org\/10.1161\/circoutcomes.115.002539","relation":{},"ISSN":["1941-7713","1941-7705"],"issn-type":[{"value":"1941-7713","type":"print"},{"value":"1941-7705","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"2015-12-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-03-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}